Associate Research Professor, Biodesign Center for Innovations in Medicine
Dr. Chris Diehnelt is an Associate Research Professor in the Center for Innovations in Medicine in the Biodesign Institute at Arizona State University. He received his Ph.D. in Analytical Chemistry from Texas A&M University in 2001 under the supervision of Emile Schweikert. He has worked for Waters Corporation and completed a post-doctoral fellowship at the US EPA prior to joining the Biodesign Institute in 2005.
His research focuses on the development of technologies for producing high-affinity, high-specificity protein binding ligands, called synbodies. Synbodies have been used for both diagnostic and therapeutic applications. He is currently focused on the use of synbodies as antimicrobials active against antimicrobial resistant bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). He is one of the inventors of the synbody technology with multiple patent filings, an issued patent and 14 peer-reviewed publications. He recently completed a successful crowd funding campaign to fund development of a synbody with MRSA activity.